A citation-based method for searching scientific literature

Jeff Sevigny, Ping Chiao, Thierry Bussière, Paul H Weinreb, Leslie Williams, Marcel Maier, Robert Dunstan, Stephen Salloway, Tianle Chen, Yan Ling, John O'Gorman, Fang Qian, Mahin Arastu, Mingwei Li, Sowmya Chollate, Melanie S Brennan, Omar Quintero-Monzon, Robert H Scannevin, H Moore Arnold, Thomas Engber, Kenneth Rhodes, James Ferrero, Yaming Hang, Alvydas Mikulskis, Jan Grimm, Christoph Hock, Roger M Nitsch, Alfred Sandrock. Nature 2016
Times Cited: 1319







List of co-cited articles
674 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The amyloid hypothesis of Alzheimer's disease at 25 years.
Dennis J Selkoe, John Hardy. EMBO Mol Med 2016
20

Donanemab in Early Alzheimer's Disease.
Mark A Mintun, Albert C Lo, Cynthia Duggan Evans, Alette M Wessels, Paul A Ardayfio, Scott W Andersen, Sergey Shcherbinin, JonDavid Sparks, John R Sims, Miroslaw Brys,[...]. N Engl J Med 2021
187
19

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Clifford R Jack, David A Bennett, Kaj Blennow, Maria C Carrillo, Billy Dunn, Samantha Budd Haeberlein, David M Holtzman, William Jagust, Frank Jessen, Jason Karlawish,[...]. Alzheimers Dement 2018
18


Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Stephen Salloway, Reisa Sperling, Nick C Fox, Kaj Blennow, William Klunk, Murray Raskind, Marwan Sabbagh, Lawrence S Honig, Anton P Porsteinsson, Steven Ferris,[...]. N Engl J Med 2014
12

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Guy M McKhann, David S Knopman, Howard Chertkow, Bradley T Hyman, Clifford R Jack, Claudia H Kawas, William E Klunk, Walter J Koroshetz, Jennifer J Manly, Richard Mayeux,[...]. Alzheimers Dement 2011
10


A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
Chad J Swanson, Yong Zhang, Shobha Dhadda, Jinping Wang, June Kaplow, Robert Y K Lai, Lars Lannfelt, Heather Bradley, Martin Rabe, Akihiko Koyama,[...]. Alzheimers Res Ther 2021
86
11

Clinical and biomarker changes in dominantly inherited Alzheimer's disease.
Randall J Bateman, Chengjie Xiong, Tammie L S Benzinger, Anne M Fagan, Alison Goate, Nick C Fox, Daniel S Marcus, Nigel J Cairns, Xianyun Xie, Tyler M Blazey,[...]. N Engl J Med 2012
9


High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis.
Suzanne E Schindler, James G Bollinger, Vitaliy Ovod, Kwasi G Mawuenyega, Yan Li, Brian A Gordon, David M Holtzman, John C Morris, Tammie L S Benzinger, Chengjie Xiong,[...]. Neurology 2019
228
8

Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.
Rachelle S Doody, Ronald G Thomas, Martin Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Rema Raman, Xiaoying Sun, Paul S Aisen,[...]. N Engl J Med 2014
984
8

Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease.
Lawrence S Honig, Bruno Vellas, Michael Woodward, Mercè Boada, Roger Bullock, Michael Borrie, Klaus Hager, Niels Andreasen, Elio Scarpini, Hong Liu-Seifert,[...]. N Engl J Med 2018
467
8

Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β.
Joseph W Arndt, Fang Qian, Benjamin A Smith, Chao Quan, Krishna Praneeth Kilambi, Martin W Bush, Thomas Walz, R Blake Pepinsky, Thierry Bussière, Stefan Hamann,[...]. Sci Rep 2018
80
8

Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia.
Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist, Ruben Smith, Thomas G Beach, Geidy E Serrano, Xiyun Chai, Nicholas K Proctor, Udo Eichenlaub, Henrik Zetterberg,[...]. Nat Med 2020
287
7

Aducanumab produced a clinically meaningful benefit in association with amyloid lowering.
Jeffrey Cummings, Paul Aisen, Cynthia Lemere, Alireza Atri, Marwan Sabbagh, Stephen Salloway. Alzheimers Res Ther 2021
60
11

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Marilyn S Albert, Steven T DeKosky, Dennis Dickson, Bruno Dubois, Howard H Feldman, Nick C Fox, Anthony Gamst, David M Holtzman, William J Jagust, Ronald C Petersen,[...]. Alzheimers Dement 2011
7

A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease.
Susanne Ostrowitzki, Robert A Lasser, Ernest Dorflinger, Philip Scheltens, Frederik Barkhof, Tania Nikolcheva, Elizabeth Ashford, Sylvie Retout, Carsten Hofmann, Paul Delmar,[...]. Alzheimers Res Ther 2017
216
7


Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Reisa A Sperling, Paul S Aisen, Laurel A Beckett, David A Bennett, Suzanne Craft, Anne M Fagan, Takeshi Iwatsubo, Clifford R Jack, Jeffrey Kaye, Thomas J Montine,[...]. Alzheimers Dement 2011
7

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.
Ganesh M Shankar, Shaomin Li, Tapan H Mehta, Amaya Garcia-Munoz, Nina E Shepardson, Imelda Smith, Francesca M Brett, Michael A Farrell, Michael J Rowan, Cynthia A Lemere,[...]. Nat Med 2008
6

Tau-targeting therapies for Alzheimer disease.
Erin E Congdon, Einar M Sigurdsson. Nat Rev Neurol 2018
424
6

High performance plasma amyloid-β biomarkers for Alzheimer's disease.
Akinori Nakamura, Naoki Kaneko, Victor L Villemagne, Takashi Kato, James Doecke, Vincent Doré, Chris Fowler, Qiao-Xin Li, Ralph Martins, Christopher Rowe,[...]. Nature 2018
664
6

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
Thomas K Karikari, Tharick A Pascoal, Nicholas J Ashton, Shorena Janelidze, Andréa Lessa Benedet, Juan Lantero Rodriguez, Mira Chamoun, Melissa Savard, Min Su Kang, Joseph Therriault,[...]. Lancet Neurol 2020
285
6

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.
Bruno Dubois, Howard H Feldman, Claudia Jacova, Harald Hampel, José Luis Molinuevo, Kaj Blennow, Steven T DeKosky, Serge Gauthier, Dennis Selkoe, Randall Bateman,[...]. Lancet Neurol 2014
6


First-in-human, double-blind, placebo-controlled, single-dose escalation study of aducanumab (BIIB037) in mild-to-moderate Alzheimer's disease.
James Ferrero, Leslie Williams, Heather Stella, Kate Leitermann, Alvydas Mikulskis, John O'Gorman, Jeff Sevigny. Alzheimers Dement (N Y) 2016
58
10


Alzheimer's disease drug development pipeline: 2019.
Jeffrey Cummings, Garam Lee, Aaron Ritter, Marwan Sabbagh, Kate Zhong. Alzheimers Dement (N Y) 2019
344
6

A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease.
Hadas Keren-Shaul, Amit Spinrad, Assaf Weiner, Orit Matcovitch-Natan, Raz Dvir-Szternfeld, Tyler K Ulland, Eyal David, Kuti Baruch, David Lara-Astaiso, Beata Toth,[...]. Cell 2017
6

Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.
Sebastian Palmqvist, Shorena Janelidze, Yakeel T Quiroz, Henrik Zetterberg, Francisco Lopera, Erik Stomrud, Yi Su, Yinghua Chen, Geidy E Serrano, Antoine Leuzy,[...]. JAMA 2020
259
6

A phase 3 trial of semagacestat for treatment of Alzheimer's disease.
Rachelle S Doody, Rema Raman, Martin Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Feng He, Xiaoying Sun, Ronald G Thomas,[...]. N Engl J Med 2013
715
6


Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
Bruno Dubois, Harald Hampel, Howard H Feldman, Philip Scheltens, Paul Aisen, Sandrine Andrieu, Hovagim Bakardjian, Habib Benali, Lars Bertram, Kaj Blennow,[...]. Alzheimers Dement 2016
791
6

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.
Clifford R Jack, David S Knopman, William J Jagust, Ronald C Petersen, Michael W Weiner, Paul S Aisen, Leslie M Shaw, Prashanthi Vemuri, Heather J Wiste, Stephen D Weigand,[...]. Lancet Neurol 2013
6

Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.
Holly Oakley, Sarah L Cole, Sreemathi Logan, Erika Maus, Pei Shao, Jeffery Craft, Angela Guillozet-Bongaarts, Masuo Ohno, John Disterhoft, Linda Van Eldik,[...]. J Neurosci 2006
6

Gamma frequency entrainment attenuates amyloid load and modifies microglia.
Hannah F Iaccarino, Annabelle C Singer, Anthony J Martorell, Andrii Rudenko, Fan Gao, Tyler Z Gillingham, Hansruedi Mathys, Jinsoo Seo, Oleg Kritskiy, Fatema Abdurrob,[...]. Nature 2016
437
5

Multi-sensory Gamma Stimulation Ameliorates Alzheimer's-Associated Pathology and Improves Cognition.
Anthony J Martorell, Abigail L Paulson, Ho-Jun Suk, Fatema Abdurrob, Gabrielle T Drummond, Webster Guan, Jennie Z Young, David Nam-Woo Kim, Oleg Kritskiy, Scarlett J Barker,[...]. Cell 2019
177
5

Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup.
Reisa A Sperling, Clifford R Jack, Sandra E Black, Matthew P Frosch, Steven M Greenberg, Bradley T Hyman, Philip Scheltens, Maria C Carrillo, William Thies, Martin M Bednar,[...]. Alzheimers Dement 2011
356
5


A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease.
Francesco Panza, Madia Lozupone, Giancarlo Logroscino, Bruno P Imbimbo. Nat Rev Neurol 2019
347
5

Current and Future Treatments in Alzheimer Disease: An Update.
Konstantina G Yiannopoulou, Sokratis G Papageorgiou. J Cent Nerv Syst Dis 2020
128
5

Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease.
Michael F Egan, James Kost, Tiffini Voss, Yuki Mukai, Paul S Aisen, Jeffrey L Cummings, Pierre N Tariot, Bruno Vellas, Christopher H van Dyck, Merce Boada,[...]. N Engl J Med 2019
250
5

Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis.
Reisa Sperling, Stephen Salloway, David J Brooks, Donatella Tampieri, Jerome Barakos, Nick C Fox, Murray Raskind, Marwan Sabbagh, Lawrence S Honig, Anton P Porsteinsson,[...]. Lancet Neurol 2012
283
5

A specific amyloid-beta protein assembly in the brain impairs memory.
Sylvain Lesné, Ming Teng Koh, Linda Kotilinek, Rakez Kayed, Charles G Glabe, Austin Yang, Michela Gallagher, Karen H Ashe. Nature 2006
5

Alzheimer's disease.
Philip Scheltens, Bart De Strooper, Miia Kivipelto, Henne Holstege, Gael Chételat, Charlotte E Teunissen, Jeffrey Cummings, Wiesje M van der Flier. Lancet 2021
226
5

Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.
Gill Livingston, Jonathan Huntley, Andrew Sommerlad, David Ames, Clive Ballard, Sube Banerjee, Carol Brayne, Alistair Burns, Jiska Cohen-Mansfield, Claudia Cooper,[...]. Lancet 2020
5

The Cellular Phase of Alzheimer's Disease.
Bart De Strooper, Eric Karran. Cell 2016
800
5

Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
Antoine Leuzy, Ruben Smith, Rik Ossenkoppele, Alexander Santillo, Edilio Borroni, Gregory Klein, Tomas Ohlsson, Jonas Jögi, Sebastian Palmqvist, Niklas Mattsson-Carlgren,[...]. JAMA Neurol 2020
67
7

Alzheimer's disease.
C A Lane, J Hardy, J M Schott. Eur J Neurol 2018
821
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.